Expiration date: 09/2026

Action:

the bone resorption inhibitor -bisphosphonate

Composition:

of zoledronic acid monohydrate, accessory: D-mannitol, sodium citrate dihydrate, water for injections

Indications:

hypercalcemia, metastatic bone lesions with malignant solid tumors and multiple myeloma, a form of primary postmenopausal osteoporosis